63 related articles for article (PubMed ID: 9765330)
1. The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding.
Gehlert DR; Dreshfield L; Tinsley F; Benvenga MJ; Gleason S; Fuller RW; Wong DT; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1998 Oct; 287(1):122-7. PubMed ID: 9765330
[TBL] [Abstract][Full Text] [Related]
2. Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain.
Gehlert DR; Schober DA; Hemrick-Luecke SK; Krushinski J; Howbert JJ; Robertson DW; Fuller RW; Wong DT
Neurochem Int; 1995 Jan; 26(1):47-52. PubMed ID: 7787762
[TBL] [Abstract][Full Text] [Related]
3. (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.
Gehlert DR; Hemrick-Luecke SK; Schober DA; Krushinski J; Howbert JJ; Robertson DW; Wong DT; Fuller RW
Life Sci; 1995; 56(22):1915-20. PubMed ID: 7746100
[TBL] [Abstract][Full Text] [Related]
4. Castration reduces olfactory bulb norepinephrine transporter function as indicated by responses to noradrenergic uptake blockers.
Shang Y; Dluzen DE
Brain Res; 1998 Jan; 779(1-2):119-24. PubMed ID: 9473620
[TBL] [Abstract][Full Text] [Related]
5. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain.
Wong DT; Bymaster FP; Reid LR; Mayle DA; Krushinski JH; Robertson DW
Neuropsychopharmacology; 1993 Jun; 8(4):337-44. PubMed ID: 8512621
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine binding to the rat norepinephrine transporter in vivo.
Owens MJ; Knight DL; Nemeroff CB
Biol Psychiatry; 2000 May; 47(9):842-5. PubMed ID: 10812044
[TBL] [Abstract][Full Text] [Related]
7. Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites.
Gehlert DR; Gackenheimer SL; Robertson DW
Neurosci Lett; 1993 Jul; 157(2):203-6. PubMed ID: 8233054
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
Gehlert DR; Schober DA; Gackenheimer SL
J Neurochem; 1995 Jun; 64(6):2792-800. PubMed ID: 7760060
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice.
Billes SK; Cowley MA
Neuropsychopharmacology; 2007 Apr; 32(4):822-34. PubMed ID: 16841072
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis.
Billes SK; Cowley MA
Neuropsychopharmacology; 2008 May; 33(6):1287-97. PubMed ID: 17687262
[TBL] [Abstract][Full Text] [Related]
12. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
Thomas GH; Babbs AJ; Chatfield RE; Krülle TM; Widdowson PS; Provost D; McCormack JG
Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
[TBL] [Abstract][Full Text] [Related]
13. Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats.
Shang Y; Dluzen DE
Neurosci Lett; 2002 Aug; 328(2):81-4. PubMed ID: 12133560
[TBL] [Abstract][Full Text] [Related]
14. Cold exposure regulates the norepinephrine uptake transporter in rat brown adipose tissue.
King VL; Dwoskin LP; Cassis LA
Am J Physiol; 1999 Jan; 276(1):R143-51. PubMed ID: 9887188
[TBL] [Abstract][Full Text] [Related]
15. Influence of age and dietary restriction on norepinephrine uptake into cardiac synaptosomes.
Snyder DL; Aloyo VJ; Wang W; Roberts J
J Cardiovasc Pharmacol; 1998 Dec; 32(6):896-901. PubMed ID: 9869494
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.
Jackson HC; Needham AM; Hutchins LJ; Mazurkiewicz SE; Heal DJ
Br J Pharmacol; 1997 Aug; 121(8):1758-62. PubMed ID: 9283714
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
Dekeyne A; Gobert A; Iob L; Cistarelli L; Melon C; Millan MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
[TBL] [Abstract][Full Text] [Related]
18. Facilitatory and inhibitory effects of selective norepinephrine reuptake inhibitors on hypogastric nerve-evoked urethral contractions in the cat: a prominent role of urethral beta-adrenergic receptors.
Springer JP; Kropp BP; Thor KB
J Urol; 1994 Aug; 152(2 Pt 1):515-9. PubMed ID: 8015105
[TBL] [Abstract][Full Text] [Related]
19. Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.
Rowland NE; Marshall M; Roth JD
Psychopharmacology (Berl); 2000 Mar; 149(1):77-83. PubMed ID: 10789886
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition.
Stahl SM
J Clin Psychiatry; 2003 Feb; 64(2):110-1. PubMed ID: 12633117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
